Clinical Trial Update: A Study To Evaluate the Effect of Rosuvastatin On Intravascular Ultrasound-Derived Coronary Atheroma Burden (ASTEROID) [Phase 3]

View source ↗

Summary

A Phase 3 study (ASTEROID) evaluating rosuvastatin's effect on intravascular ultrasound-derived coronary atheroma burden has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Drugs mentioned

• Rosuvastatin (rosuvastatin)

Snippet

Sponsor: AstraZeneca | Conditions: Coronary Arteriosclerosis | Phase 3 | Status: COMPLETED